0.9% SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9% sodium chloride 50 mL intravenous infusion Australien - engelska - Department of Health (Therapeutic Goods Administration)

0.9% sodium chloride intravenous infusion bp 0.9% sodium chloride 50 ml intravenous infusion

b braun australia pty ltd - sodium chloride, quantity: 0.45 g - injection, solution - excipient ingredients: water for injections - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established. 0.9% sodium chloride injection may also be used for irrigation of wounds and moistening of wound dressings. compound sodium lactate solution is particularly suitable for the replacement of extracellular fluid loss where isotonic dehydration is evident and in burn therapy.

LACTATED RINGERS- sodium chloride, sodium lactate, potassium chloride, and calcium chloride injection, solution USA - engelska - NLM (National Library of Medicine)

lactated ringers- sodium chloride, sodium lactate, potassium chloride, and calcium chloride injection, solution

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - sodium chloride 0.6 g in 100 ml - this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. the use of lactated ringer’s injection usp is contraindicated in neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see warnings, drug interactions, pediatric use ]. this solution is contraindicated where the administration of sodium, potassium, calcium, lactate, or chloride could be clinically detrimental. lactate administration is contraindicated in severe metabolic acidosis or alkalosis, and in severe liver disease or anoxic states which affect lactate metabolism.

Sodium chloride 5 mmol/ml Oral Solution Irland - engelska - HPRA (Health Products Regulatory Authority)

sodium chloride 5 mmol/ml oral solution

syri limited, t/a thame laboratories - sodium chloride - oral solution - 5 millimole(s)/millilitre - sodium chloride

SODIUM CHLORIDE (0.22%) AND GLUCOSE (10%) INTRAVENOUS INFUSION BP solution for injection bag Australien - engelska - Department of Health (Therapeutic Goods Administration)

sodium chloride (0.22%) and glucose (10%) intravenous infusion bp solution for injection bag

baxter healthcare pty ltd - sodium chloride, quantity: 1.1 g; glucose, quantity: 50 g - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations, it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Sodium chloride 5 mmol/ml Oral Solution Irland - engelska - HPRA (Health Products Regulatory Authority)

sodium chloride 5 mmol/ml oral solution

syri pharma limited t/a thame laboratories - sodium chloride - oral solution - 5 millimole(s)/millilitre - sodium chloride

Sodium Chloride 0.3 % w/v and Glucose 3.3% w/v Solution for Infusion BP Irland - engelska - HPRA (Health Products Regulatory Authority)

sodium chloride 0.3 % w/v and glucose 3.3% w/v solution for infusion bp

baxter healthcare limited - sodium chloride; glucose monohydrate - solution for infusion - 0.3 3.3 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP Irland - engelska - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45 % w/v and glucose 2.5% w/v solution for infusion bp

baxter healthcare limited - sodium chloride; sodium chloride; glucose monohydrate; glucose monohydrate - solution for infusion - 0.45 2.5 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) Irland - engelska - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9 % w/v and glucose 5% w/v solution for infusion bp (viaflo container)

baxter healthcare limited - sodium chloride; sodium chloride; glucose monohydrate; glucose monohydrate - solution for infusion - 0.9/5 %w/v percent weight/volume - salt solutions; sodium chloride

Baxter 0.45% Sodium Chloride and 5% Glucose Intravenous Infusion 1000 mL bag (AHB6028) Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 5% glucose intravenous infusion 1000 ml bag (ahb6028)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections; hydrochloric acid - sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Sodium Chloride 0.3 % w/v and Glucose 3.3% w/v Solution for Infusion BP Irland - engelska - HPRA (Health Products Regulatory Authority)

sodium chloride 0.3 % w/v and glucose 3.3% w/v solution for infusion bp

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.3/ 3.3 percent weight/volume - salt solutions; sodium chloride